프로세스 분석 기술 시장 예측(-2031년) : 기술별, 제품·서비스별, 측정별, 용도별, 지역별

The global process analytical technology market is projected to reach USD 11.49 billion by 2031 from USD 5.79 billion in 2026, at a CAGR of 14.7% during the forecast period. A growing number of pharmaceutical & biopharmaceutical R&D activities and technological advancements that enable process optimization are key factors driving market growth.

However, the shortage of skilled professionals and the high cost of PAT deployment are hindering market growth.

"The analyzers segment accounted for the largest market share in 2025"

Analyzers accounted for the largest share of the process analytical technology market due to their essential role in real-time process monitoring, quality control, and measurement of critical process parameters throughout pharmaceutical and biopharmaceutical manufacturing. Their widespread adoption for ensuring product consistency, regulatory compliance, and continuous manufacturing efficiency further strengthened their market position.

"In terms of application, small molecules held the largest share of the market in 2025"

Based on application, the process analytical technology market is broadly segmented into small molecules, large molecules, manufacturing applications, and other applications. The small-molecule segment commanded the largest share of the market in 2025. This is due to their widespread use in pharmaceutical manufacturing and the increasing number of companies focused on small-molecule drug development. PAT tools such as spectroscopy, chromatography, calorimetry, and particle size analysis are extensively utilized throughout the small-molecule drug development and manufacturing process to ensure product quality, process efficiency, and regulatory compliance. Additionally, growing pharmaceutical R&D activities, stringent drug safety requirements, and rising demand for generic drugs and biosimilars continue to drive the adoption of PAT solutions in small-molecule production, supporting the segment's dominant market position.

"The Asia Pacific is expected to witness the highest growth during the forecast period."

The Asia Pacific is expected to register the highest CAGR during the forecast period due to the rapid expansion of pharmaceutical and biopharmaceutical manufacturing, the growing contract research and manufacturing services (CRAMS) industry, and increasing investments by key market players in countries such as China, India, Japan, South Korea, and Singapore. Additionally, the establishment of new manufacturing facilities and R&D centers, rising adoption of advanced analytical technologies, supportive government initiatives, and increasing healthcare demand driven by aging populations and expanding pharmaceutical production are accelerating PAT adoption across the region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: C-level-10%, Managers-76%, and Others-14%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and the Middle East & Africa-2%

The prominent players in the process analytical technology market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bruker Corporation (US), Emerson Electric Co. (US), ABB Ltd. (Switzerland), PerkinElmer, Inc. (US), Mettler-Toledo International Inc. (US), and Carl Zeiss AG (Germany), among others.

Research Coverage

This report studies the process analytical technology market based on technology, measurement, product & service, application, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies for strengthening their market presence.

This report provides insights into the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the process analytical technology market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the process analytical technology market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the process analytical technology market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 INCLUSIONS & EXCLUSIONS
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 DISRUPTIVE TRENDS IN PROCESS ANALYTICAL TECHNOLOGY MARKET
• 2.3 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 PROCESS ANALYTICAL TECHNOLOGY MARKET OVERVIEW
• 3.2 PROCESS ANALYTICAL & TECHNOLOGY MARKET, BY REGION
• 3.3 NORTH AMERICA: PROCESS ANALYTICAL & TECHNOLOGY MARKET, BY TECHNOLOGY, 2025
• 3.4 GEOGRAPHIC SNAPSHOT OF PROCESS ANALYTICAL TECHNOLOGY MARKET

4 MARKET OVERVIEW

• 4.1 MARKET DYNAMICS
  • 4.1.1 DRIVERS
    • 4.1.1.1 Growing pharmaceutical industry & increasing R&D investments by biopharmaceutical firms
    • 4.1.1.2 Government regulations on drug safety
    • 4.1.1.3 Rising need for quality improvements in manufacturing processes
    • 4.1.1.4 Technological advancements in analytical devices
  • 4.1.2 RESTRAINTS
    • 4.1.2.1 High cost of PAT deployment
  • 4.1.3 OPPORTUNITIES
    • 4.1.3.1 Integration of AI- and machine learning-enabled PAT
    • 4.1.3.2 Growing adoption of analytical instruments in biopharmaceutical processes
    • 4.1.3.3 Emerging applications in cell and gene therapy manufacturing
  • 4.1.4 CHALLENGES
    • 4.1.4.1 Shortage of skilled professionals

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
  • 5.2.4 TRENDS IN GLOBAL PROCESS ANALYTICAL INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
  • 5.3.1 RAW MATERIAL
  • 5.3.2 MANUFACTURING
  • 5.3.3 SALES & DISTRIBUTION
  • 5.3.4 APPLICATIONS
• 5.4 VALUE CHAIN ANALYSIS
  • 5.4.1 RESEARCH & DEVELOPMENT
  • 5.4.2 RAW MATERIAL PROCUREMENT
  • 5.4.3 MANUFACTURING
  • 5.4.4 DISTRIBUTION
  • 5.4.5 MARKETING & SALES
  • 5.4.6 POST-SALE SERVICES
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
• 5.7 TRADE ANALYSIS
• 5.8 KEY CONFERENCES AND EVENTS (2026-2027)
• 5.9 TRENDS IMPACTING CUSTOMER BUSINESS
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
• 5.12 IMPACT OF 2025 US TARIFF
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 KEY TARIFF RATES
  • 5.12.4 PRICE IMPACT ANALYSIS
  • 5.12.5 IMPACT ON COUNTRY/REGION
    • 5.12.5.1 US
    • 5.12.5.2 Europe
    • 5.12.5.3 Asia Pacific
  • 5.12.6 IMPACT ON END USERS

6 PROCESS ANALYTICAL TECHNOLOGY MARKET, BY TECHNOLOGY

• 6.1 INTRODUCTION
• 6.2 SPECTROSCOPY
  • 6.2.1 MOLECULAR SPECTROSCOPY
    • 6.2.1.1 Raman spectroscopy
      • 6.2.1.1.1 Growing adoption across various industries to drive segment growth
    • 6.2.1.2 Infrared spectroscopy (IR)
      • 6.2.1.2.1 Rising technological advancements to support segment growth
    • 6.2.1.3 Other molecular spectroscopy
      • 6.2.1.3.1 Expansion of advanced PAT capabilities through emerging molecular spectroscopy technologies to boost growth
  • 6.2.2 MASS SPECTROMETRY
    • 6.2.2.1 Growing demand for high-resolution analytical platforms to drive segment growth
  • 6.2.3 ATOMIC SPECTROSCOPY
    • 6.2.3.1 Wide applications in drug research to drive market
• 6.3 CHROMATOGRAPHY
  • 6.3.1 LIQUID CHROMATOGRAPHY (LC) SYSTEMS
    • 6.3.1.1 High adoption of HPLC systems in analytical & preparative analytical applications to support market growth
  • 6.3.2 GAS CHROMATOGRAPHY SYSTEMS
    • 6.3.2.1 Innovation in gas chromatography for pharmaceutical quality control
  • 6.3.3 OTHER CHROMATOGRAPHY SYSTEMS
• 6.4 PARTICLE SIZE ANALYSIS
  • 6.4.1 AI-ENABLED PARTICLE SIZE ANALYSIS DRIVING PROCESS CONTROL
• 6.5 CAPILLARY ELECTROPHORESIS
  • 6.5.1 ADVANCEMENTS IN CAPILLARY ELECTROPHORESIS FOR HIGH-RESOLUTION BIOPHARMACEUTICAL ANALYSIS
• 6.6 OTHER TECHNOLOGIES

7 PROCESS ANALYTICAL TECHNOLOGY MARKET, BY PRODUCT & SERVICE

• 7.1 INTRODUCTION
• 7.2 PRODUCT
  • 7.2.1 ANALYZERS
    • 7.2.1.1 Rising technological advancements to support segment growth
  • 7.2.2 SENSORS & PROBES
    • 7.2.2.1 Advancements in smart sensors and probes for real-time process monitoring
  • 7.2.3 SAMPLERS
    • 7.2.3.1 Accuracy and high reproducibility to drive the market
• 7.3 SERVICES
  • 7.3.1 MANDATORY IMPLEMENTATION OF PAT FRAMEWORK IN PHARMACEUTICAL COMPANIES TO SUPPORT MARKET GROWTH

8 PROCESS ANALYTICAL TECHNOLOGY MARKET, BY MEASUREMENT

• 8.1 INTRODUCTION
• 8.2 ON-LINE MEASUREMENT
  • 8.2.1 ACHIEVE FLEXIBLE REAL-TIME MONITORING THROUGH ONLINE MEASUREMENT
• 8.3 IN-LINE MEASUREMENT
  • 8.3.1 CONTINUOUS REAL-TIME PROCESS MONITORING TO DRIVE MARKET
• 8.4 AT-LINE MEASUREMENT
  • 8.4.1 BALANCED SPEED AND ACCURACY WITH AT-LINE MEASUREMENT TO BOOST GROWTH
• 8.5 OFF-LINE MEASUREMENT
  • 8.5.1 COMPREHENSIVE LABORATORY-BASED QUALITY VERIFICATION TO DRIVE MARKET

9 PROCESS ANALYTICAL TECHNOLOGY MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 SMALL MOLECULES
  • 9.2.1 MANUFACTURING QC/QA
    • 9.2.1.1 API manufacturing process widely utilizes chromatography techniques
  • 9.2.2 DRUG DISCOVERY & DEVELOPMENT
    • 9.2.2.1 Growing structural complexity of modern APIs, including peptides, GLP-1 analogs, and oligonucleotides drives growth
• 9.3 LARGE MOLECULES
  • 9.3.1 MANUFACTURING QC/QA
    • 9.3.1.1 Strengthen large-molecule manufacturing QC/QA through advanced PAT solutions
  • 9.3.2 DRUG DISCOVERY & DEVELOPMENT
    • 9.3.2.1 Accelerate large-molecule drug development through AI-enabled PAT and advanced analytical technologies
• 9.4 MANUFACTURING APPLICATIONS
  • 9.4.1 ACCELERATED PHARMACEUTICAL MANUFACTURING THROUGH PAT-ENABLED CONTINUOUS PROCESSING
• 9.5 OTHER APPLICATIONS

10 PROCESS ANALYTICAL TECHNOLOGY MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 STRINGENT DRUG DEVELOPMENT REGULATIONS AND PRESENCE OF PHARMA & BIOPHARMA COMPANIES TO DRIVE MARKET
  • 10.2.2 US
    • 10.2.2.1 AI-enabled analytical technologies support PAT market growth
  • 10.2.3 CANADA
    • 10.2.3.1 Expanding biomanufacturing capacity drives PAT adoption
• 10.3 EUROPE
  • 10.3.1 ADVANCED PHARMACEUTICAL MANUFACTURING THROUGH PAT TO BOOST MARKET
  • 10.3.2 UK
    • 10.3.2.1 Leveraging advanced analytical instrumentation to drive PAT adoption
  • 10.3.3 GERMANY
    • 10.3.3.1 Advancing continuous bioprocessing through integrated PAT technologies to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Smart biomanufacturing through modular PAT integration - key driver
  • 10.3.5 ITALY
    • 10.3.5.1 Strong PAT adoption through CDMO expansion and advanced pharmaceutical manufacturing to propel market
  • 10.3.6 SPAIN
    • 10.3.6.1 Increase in biologics and API manufacturing capacity to boost market
  • 10.3.7 REST OF EUROPE
    • 10.3.7.1 Biopharmaceutical innovation and advanced manufacturing to expand PAT adoption
• 10.4 ASIA PACIFIC
  • 10.4.1 ACCELERATED ADOPTION DUE TO BIOPHARMACEUTICAL EXPANSION AND DIGITAL MANUFACTURING
  • 10.4.2 JAPAN
    • 10.4.2.1 Advanced chromatography and electrophoresis technologies for pharmaceutical manufacturing to drive market
  • 10.4.3 CHINA
    • 10.4.3.1 Enhanced PAT adoption through regulatory harmonization and biopharmaceutical expansion
  • 10.4.4 INDIA
    • 10.4.4.1 Market growth driven by PAT adoption through biopharmaceutical growth and CDMO expansion
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Regulatory compliance and advanced biomanufacturing drive PAT adoption
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 PAT adoption through biologics innovation and digital manufacturing to bost market
  • 10.4.7 REST OF ASIA PACIFIC
    • 10.4.7.1 Accelerated pharmaceutical modernization through process analytical technology adoption
• 10.5 LATIN AMERICA
  • 10.5.1 GROWING BIOPHARMACEUTICAL & PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
  • 10.5.2 BRAZIL
    • 10.5.2.1 Regulatory modernization and pharmaceutical quality standards to drive market
  • 10.5.3 MEXICO
    • 10.5.3.1 Pharmaceutical manufacturing investments accelerate PAT adoption
  • 10.5.4 REST OF LATIN AMERICA
    • 10.5.4.1 Expanding pharmaceutical manufacturing and regulatory modernization support PAT adoption
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 LOCALIZATION INITIATIVES AND PHARMACEUTICAL MANUFACTURING EXPANSION DRIVE PAT ADOPTION
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Vision 2030 and biotechnology investments accelerate PAT adoption
  • 10.6.3 REST OF MIDDLE EAST & AFRICA
    • 10.6.3.1 Local pharmaceutical manufacturing and regulatory harmonization drive PAT adoption

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES
  • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN PROCESS ANALYTICAL TECHNOLOGY MARKET
• 11.3 REVENUE SHARE ANALYSIS
• 11.4 COMPANY EVALUATION MATRIX
  • 11.4.1 STARS
  • 11.4.2 EMERGING LEADERS
  • 11.4.3 PERVASIVE PLAYERS
  • 11.4.4 PARTICIPANTS
• 11.5 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2025)
  • 11.5.1 PROGRESSIVE COMPANIES
  • 11.5.2 STARTING BLOCKS
  • 11.5.3 RESPONSIVE COMPANIES
  • 11.5.4 DYNAMIC COMPANIES
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product & service footprint
    • 11.5.5.4 Technology footprint
    • 11.5.5.5 Measurement footprint
    • 11.5.5.6 Application footprint
  • 11.5.6 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
• 11.6 COMPANY VALUATION & FINANCIAL METRICS
  • 11.6.1 FINANCIAL METRICS
  • 11.6.2 COMPANY VALUATION
• 11.7 BRAND/PRODUCT COMPARISON
• 11.8 COMPETITIVE SITUATION AND TRENDS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 THERMO FISHER SCIENTIFIC INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 AGILENT TECHNOLOGIES, INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 WATERS CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches & approvals
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 DANAHER
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches & approvals
      • 12.1.4.3.2 Deals
      • 12.1.4.3.3 Expansions
  • 12.1.5 PERKINELMER INC.
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches & approvals
      • 12.1.5.3.2 Deals
  • 12.1.6 SHIMADZU CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches & approvals
      • 12.1.6.3.2 Deals
      • 12.1.6.3.3 Expansions
  • 12.1.7 BRUKER CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches & approvals
      • 12.1.7.3.2 Deals
      • 12.1.7.3.3 Expansions
  • 12.1.8 METTLER-TOLEDO INTERNATIONAL INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Deals
  • 12.1.9 CARL ZEISS AG (ZEISS GROUP)
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 EMERSON ELECTRIC CO.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches & approvals
  • 12.1.11 ABB
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Expansions
  • 12.1.12 SARTORIUS AG
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
      • 12.1.12.3.2 Expansions
  • 12.1.13 MERCK KGAA
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Deals
  • 12.1.14 VERUM ANALYTICS, LLC
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 PROCESS INSIGHTS, INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 HAMILTON COMPANY
  • 12.2.2 ENDRESS+HAUSER GROUP SERVICES AG
  • 12.2.3 VIAVI SOLUTIONS INC.
  • 12.2.4 METROHM AG
  • 12.2.5 CONTROL DEVELOPMENT, INC.
  • 12.2.6 SCHMIDT + HAENSCH
  • 12.2.7 SENSUM D.O.O.
  • 12.2.8 SKYRAY INSTRUMENTS USA, INC.
  • 12.2.9 AMETEK, INC.
  • 12.2.10 SENTRONIC GMBH

13 RESEARCH METHODOLOGY

• 13.1 RESEARCH DATA
  • 13.1.1 SECONDARY DATA
    • 13.1.1.1 Objectives of secondary research
    • 13.1.1.2 List of secondary sources
    • 13.1.1.3 Primary data
    • 13.1.1.4 Key industry insights
• 13.2 MARKET SIZE ESTIMATION
  • 13.2.1 BOTTOM-UP APPROACH
  • 13.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 13.2.2.1 Approach 2: Customer-based market estimation
  • 13.2.3 PRIMARY RESEARCH VALIDATION
  • 13.2.4 TOP-DOWN APPROACH
• 13.3 DATA TRIANGULATION
• 13.4 RESEARCH ASSUMPTIONS
• 13.5 RESEARCH LIMITATIONS
• 13.6 RISK ASSESSMENT
  • 13.6.1 RISK ASSESSMENT: PROCESS ANALYTICAL TECHNOLOGY MARKET

14 APPENDIX

• 14.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.2 CUSTOMIZATION OPTIONS
• 14.3 RELATED REPORTS
• 14.4 AUTHOR DETAILS